Sucksdorff, M., Tuisku, J., Matilainen, M., Vuorimaa, A., Smith, S., Keitilä, J., . . . Airas, L. (2019). Natalizumab treatment reduces microglial activation in the white matter of the MS brain. Neurol Neuroimmunol Neuroinflamm.
Chicago Style aipamenaSucksdorff, Marcus, et al. "Natalizumab Treatment Reduces Microglial Activation in the White Matter of the MS Brain." Neurol Neuroimmunol Neuroinflamm 2019.
MLA aipamenaSucksdorff, Marcus, et al. "Natalizumab Treatment Reduces Microglial Activation in the White Matter of the MS Brain." Neurol Neuroimmunol Neuroinflamm 2019.
Kontuz: berrikusi erreferentzia hauek erabili aurretik.